Q and A: about health and research

JAK inhibitors and nonsteroidal anti-inflammatory drugs (NSAIDs) are both critical tools in the management of inflammation and autoimmune diseases. Although they share the common goal of reducing inflammation, they operate through entirely different biological mechanisms. This distinction allows for tailored treatment strategies, especially in complex, chronic inflammatory conditions like ankylosing spondylitis or rheumatoid arthritis. How They Work JAK Inhibitors JAK inhibitors target the Janus Kinase (JAK) family of enzymes. These enzymes play a central role in the JAK-STAT signaling pathway , which is crucial in mediating immune responses and inflammation. When this pathway is overactive, as in many autoimmune diseases, JAK inhibitors can help reduce the excessive immune response and inflammation by blocking intracellular signals that promote cytokine production. NSAIDs NSAIDs—such as ibuprofen, naproxen, and celecoxib—work by inhibiting cyclooxygenase (COX) enzymes, partic...

Introduction The immune system is a complex and highly coordinated network of cells and molecules that protect the body from infections, eliminate harmful substances, and clear dead or damaged cells. Among its key components are opsonins —specialized proteins that play a pivotal role in enhancing the ability of immune cells to recognize, engulf, and destroy invading pathogens and cellular debris. Although not as commonly discussed as antibodies or white blood cells, opsonins are fundamental to effective immune function. This article provides an in-depth examination of opsonins, how they work, their biological significance, consequences of their malfunction, and the clinical relevance of their function. What Are Opsonins? Opsonins are proteins that act as molecular "tags," binding to the surface of foreign invaders (such as bacteria and viruses), as well as to dead or dying host cells. This process, known as opsonization , marks these targets for destruction or clearance ...